<html><body><b><i>Business Combinations</i></b><p style="margin-top:0px;margin-bottom:-6px"><font size="1"></font></p><p style="margin-top:0px;margin-bottom:0px; text-indent:4%"><font size="2" style="font-family:Times New Roman">We allocate the purchase price of acquired businesses to the tangible and intangible assets acquired and
liabilities assumed based upon their estimated fair values on the acquisition date. The purchase price allocation process requires management to make significant estimates and assumptions, especially at the acquisition date with respect to
intangible assets and in-process research and development (IPR&amp;D). In connection with the purchase price allocations for acquisitions, we estimate the fair value of contingent consideration payments utilizing a probability-based income approach
inclusive of an estimated discount rate.</font></p><p style="margin-top:0px;margin-bottom:0px"><font size="1"></font></p><p style="margin-top:0px;margin-bottom:0px; text-indent:4%"><font size="2" style="font-family:Times New Roman">Although
we believe the assumptions and estimates made are reasonable, they are based in part on historical experience and information obtained from the management of the acquired businesses and are inherently uncertain. Examples of critical estimates in
valuing certain of the intangible assets and any contingent consideration we have acquired or may acquire in the future include but are not limited to:</font></p><p style="margin-top:0px;margin-bottom:-6px"><font size="1"></font></p><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE" width="100%">
<tr>
<td width="4%"><font size="1"></font></td>
<td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td>
<td valign="top" width="1%"></td>
<td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">the feasibility and timing of achievement of development, regulatory and commercial milestones;</font></p></td></tr></table><tr>
<td width="4%"><font size="1"></font></td>
<td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td>
<td valign="top" width="1%"></td>
<td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">the feasibility and timing of achievement of development, regulatory and commercial milestones;</font></p></td></tr><td width="4%"><font size="1"></font></td><td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td><td valign="top" width="1%"></td><td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">the feasibility and timing of achievement of development, regulatory and commercial milestones;</font></p></td><p align="left"><font size="2" style="font-family:Times New Roman">the feasibility and timing of achievement of development, regulatory and commercial milestones;</font></p><p style="margin-top:0px;margin-bottom:-6px"><font size="1"></font></p><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE" width="100%">
<tr>
<td width="4%"><font size="1"></font></td>
<td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td>
<td valign="top" width="1%"></td>
<td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">expected costs to develop the in-process research and development into commercially viable products; and</font></p></td></tr></table><tr>
<td width="4%"><font size="1"></font></td>
<td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td>
<td valign="top" width="1%"></td>
<td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">expected costs to develop the in-process research and development into commercially viable products; and</font></p></td></tr><td width="4%"><font size="1"></font></td><td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td><td valign="top" width="1%"></td><td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">expected costs to develop the in-process research and development into commercially viable products; and</font></p></td><p align="left"><font size="2" style="font-family:Times New Roman">expected costs to develop the in-process research and development into commercially viable products; and</font></p><p style="margin-top:0px;margin-bottom:-6px"><font size="1"></font></p><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE" width="100%">
<tr>
<td width="4%"><font size="1"></font></td>
<td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td>
<td valign="top" width="1%"></td>
<td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">future expected cash flows from product sales. </font></p></td></tr></table><tr>
<td width="4%"><font size="1"></font></td>
<td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td>
<td valign="top" width="1%"></td>
<td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">future expected cash flows from product sales. </font></p></td></tr><td width="4%"><font size="1"></font></td><td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td><td valign="top" width="1%"></td><td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">future expected cash flows from product sales. </font></p></td><p align="left"><font size="2" style="font-family:Times New Roman">future expected cash flows from product sales. </font></p><p style="margin-top:0px;margin-bottom:0px"><font size="1"></font></p><p style="margin-top:0px;margin-bottom:0px; text-indent:4%"><font size="2" style="font-family:Times New Roman">Unanticipated events and circumstances may occur which may
affect the accuracy or validity of such assumptions, estimates or actual results. </font></p><p style="margin-top:0px;margin-bottom:0px"><font size="1"></font></p><p style="margin-top:0px;margin-bottom:0px; margin-left:2%"><font size="2" style="font-family:Times New Roman"><b><i>Valuation of Contingent Acquisition Consideration Payable </i></b></font></p><p style="margin-top:0px;margin-bottom:-6px"><font size="1"></font></p><p style="margin-top:0px;margin-bottom:0px; text-indent:4%"><font size="2" style="font-family:Times New Roman">Each period we reassess the fair value of the contingent acquisition consideration payable associated with certain acquisitions and record
increases in the fair value as contingent consideration expense and record decreases in the fair value as a reduction of contingent consideration expense. Increases or decreases in the fair value of the contingent acquisition consideration payable
can result from changes in assumed probability adjustments with respect to regulatory approval, changes in the assumed timing of when milestones will be achieved and changes in assumed discount periods and rates. Significant judgment is employed in
determining the appropriateness of these assumptions each period. Accordingly, future business and economic conditions, as well as changes in any of the assumptions described in the accounting for business combinations above can materially impact
the amount of contingent consideration expense that we record in any given period. </font></p></body></html>